In concordance with earlier reports that tumour infiltrating FOXP3+, CD8+ and CD45RO+ T cells are associated with better patient survival[8], [10], [28], [36], our study confirms the importance of T cell density as a prognostic marker in CRC. This evidence concerns the gene CD8A and colorectal carcinoma.